108 related articles for article (PubMed ID: 25096793)
1. CYP1A2 phenotyping in dried blood spots and microvolumes of whole blood and plasma.
De Kesel PM; Lambert WE; Stove CP
Bioanalysis; 2014; 6(22):3011-24. PubMed ID: 25096793
[TBL] [Abstract][Full Text] [Related]
2. Why dried blood spots are an ideal tool for CYP1A2 phenotyping.
De Kesel PM; Lambert WE; Stove CP
Clin Pharmacokinet; 2014 Aug; 53(8):763-71. PubMed ID: 24980692
[TBL] [Abstract][Full Text] [Related]
3. Does volumetric absorptive microsampling eliminate the hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative study.
De Kesel PM; Lambert WE; Stove CP
Anal Chim Acta; 2015 Jun; 881():65-73. PubMed ID: 26041521
[TBL] [Abstract][Full Text] [Related]
4. Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?
De Kesel PM; Lambert WE; Stove CP
Clin Pharmacokinet; 2015 Jul; 54(7):771-81. PubMed ID: 25603821
[TBL] [Abstract][Full Text] [Related]
5. Potassium-based algorithm allows correction for the hematocrit bias in quantitative analysis of caffeine and its major metabolite in dried blood spots.
De Kesel PM; Capiau S; Stove VV; Lambert WE; Stove CP
Anal Bioanal Chem; 2014 Oct; 406(26):6749-55. PubMed ID: 25168119
[TBL] [Abstract][Full Text] [Related]
6. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume.
Vu DH; Koster RA; Alffenaar JW; Brouwers JR; Uges DR
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1063-70. PubMed ID: 21459055
[TBL] [Abstract][Full Text] [Related]
7. Validation of a high-performance liquid chromatography assay for quantification of caffeine and paraxanthine in human serum in the context of CYP1A2 phenotyping.
Koch JP; ten Tusscher GW; Koppe JG; Guchelaar HJ
Biomed Chromatogr; 1999 Jun; 13(4):309-14. PubMed ID: 10416066
[TBL] [Abstract][Full Text] [Related]
8. Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.
Perera V; Gross AS; McLachlan AJ
Biomed Chromatogr; 2010 Oct; 24(10):1136-44. PubMed ID: 20853468
[TBL] [Abstract][Full Text] [Related]
9. An optimized and validated SPE-LC-MS/MS method for the determination of caffeine and paraxanthine in hair.
De Kesel PM; Lambert WE; Stove CP
Talanta; 2015 Nov; 144():62-70. PubMed ID: 26452792
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Performance and Hematocrit Independence of the HemaPEN as a Volumetric Dried Blood Spot Collection Device.
Deprez S; Paniagua-González L; Velghe S; Stove CP
Anal Chem; 2019 Nov; 91(22):14467-14475. PubMed ID: 31638372
[TBL] [Abstract][Full Text] [Related]
11. Analysis of caffeine and paraxanthine in human saliva with ultra-high-performance liquid chromatography for CYP1A2 phenotyping.
Jordan NY; Mimpen JY; van den Bogaard WJ; Flesch FM; van de Meent MH; Torano JS
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jul; 995-996():70-3. PubMed ID: 26038236
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a reversed-phase HPLC method for CYP1A2 phenotyping by use of a caffeine metabolite ratio in saliva.
Begas E; Kouvaras E; Tsakalof AK; Bounitsi M; Asprodini EK
Biomed Chromatogr; 2015 Nov; 29(11):1657-63. PubMed ID: 25891161
[TBL] [Abstract][Full Text] [Related]
13. Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.
Fuhr U; Rost KL
Pharmacogenetics; 1994 Jun; 4(3):109-16. PubMed ID: 7920690
[TBL] [Abstract][Full Text] [Related]
14. Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies.
Li Y; Henion J; Abbott R; Wang P
Bioanalysis; 2011 Nov; 3(22):2501-14. PubMed ID: 22122599
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantitation of serum caffeine and its metabolites by ultra-high-performance liquid chromatography-tandem mass spectrometry for CYP1A2 activity prediction in premature infants.
Jiang Z; Gao X; Liang J; Ni S
Biomed Chromatogr; 2021 Sep; 35(9):e5141. PubMed ID: 34041763
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Capitainer-B Microfluidic Device as a New Hematocrit-Independent Alternative for Dried Blood Spot Collection.
Velghe S; Stove CP
Anal Chem; 2018 Nov; 90(21):12893-12899. PubMed ID: 30256092
[TBL] [Abstract][Full Text] [Related]
17. Development of a validated LC-MS/MS method for determination of doxofylline on rat dried blood spots and urine: application to pharmacokinetics.
Rao RN; Prasad KG; Naidu ChG; Saida S; Agwane SB
J Pharm Biomed Anal; 2013 May; 78-79():211-6. PubMed ID: 23501441
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma.
Bosilkovska M; Déglon J; Samer C; Walder B; Desmeules J; Staub C; Daali Y
Bioanalysis; 2014 Jan; 6(2):151-64. PubMed ID: 24423593
[TBL] [Abstract][Full Text] [Related]
19. Application of dried blood spot sampling combined with LC-MS/MS for genotyping and phenotyping of CYP450 enzymes in healthy volunteers.
de Boer T; Wieling J; Meulman E; Reuvers M; Renkema G; den Daas I; van Iersel T; Wemer J; Chen L
Biomed Chromatogr; 2011 Oct; 25(10):1112-23. PubMed ID: 21287583
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of pregabalin in dried blood spots and dried plasma spots by validated LC-MS/MS methods.
Kostić N; Dotsikas Y; Jović N; Stevanović G; Malenović A; Medenica M
J Pharm Biomed Anal; 2015 May; 109():79-84. PubMed ID: 25767905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
